NewPhase3DataShowTakeda’sDengueVaccineDelivers7YearsofSustainedProtectionAgainstInfectionandHospitalization
===2025/11/4 10:15:35===
ve transformed global public health.9For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19 and pandemic flu. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development and manufacturing to advance a pipeline of vaccines to address some of the world’s most pressing public health needs.
About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of tre
=*=*=*=*=*=
当前为第13/21页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页